Viewing Study NCT03280667


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-01-07 @ 12:57 AM
Study NCT ID: NCT03280667
Status: UNKNOWN
Last Update Posted: 2023-03-29
First Post: 2017-09-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module